Estrella Immunopharma, Inc.
ESLA
$0.94
$0.12915.91%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/5/2025
-
GuruFocus
3/5/2025
-
Business Wire
2/21/2025
-
GuruFocus
2/21/2025
-
The Fly
2/21/2025
-
Business Wire
2/19/2025
-
GuruFocus
2/19/2025
-
Business Wire
2/18/2025
-
The Fly
12/12/2024
-
SeekingAlpha.com: All News
12/12/2024
-
TipRanks Financial Blog
12/12/2024
-
The Fly
11/14/2024
-
Simply Wall St
10/11/2024
-
Ticker Report
9/27/2024
-
Business Wire
9/27/2024
-
Zolmax
8/20/2024
-
TipRanks Financial Blog
8/14/2024
-
The Fly
8/14/2024
-
Business Wire
8/2/2024
-
InvestorPlace
7/13/2024
-
Ticker Report
6/18/2024
-
Zolmax
6/18/2024
-
Ticker Report
5/20/2024
-
InvestorPlace
5/13/2024
-
Zolmax
4/12/2024
-
Ticker Report
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 318 9098
Address
5858 Horton Street
EmeryVille, CA 94608
EmeryVille, CA 94608
Country
Year Founded
Business Description
Sector
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company’s lead product candidates...
more
